APREPITANT
Generic: APREPITANT
Golden State Medical SupplyManufacturer
ORALRoute
APREPITANTActive Substance
2020-10-21Original Approval
APREPITANT is FDA application ANDA211835, sponsored by TORRENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06cGMP deviations: Temperature abuse
Class III2018-11-27
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark PharmaceuticaShortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in
Top Reported Reactions
1
FATIGUE
1,223 reports
2
NAUSEA
1,066 reports
3
PYREXIA
895 reports
4
OFF LABEL USE
845 reports
5
ALOPECIA
805 reports
6
DYSPNOEA
767 reports
7
RASH
745 reports
8
DIARRHOEA
730 reports
9
HYPERSENSITIVITY
681 reports
10
VOMITING
676 reports